Can Hypothyroidism Cause Raised Homocysteine Levels?
Yes, hypothyroidism definitively causes elevated homocysteine levels, and this relationship is independent of other cardiovascular risk factors. The evidence consistently demonstrates that hypothyroid patients have significantly higher homocysteine concentrations compared to euthyroid controls, with thyroid hormone replacement partially normalizing these levels 1.
The Mechanism and Evidence
Hypothyroidism decreases hepatic levels of enzymes involved in the remethylation pathway of homocysteine metabolism, particularly affecting methylenetetrahydrofolate reductase (MTHFR) activity 2, 3. This enzymatic impairment leads to accumulation of homocysteine in the bloodstream.
Key Clinical Findings:
- Magnitude of elevation: Hypothyroid patients demonstrate fasting homocysteine levels of approximately 13.0 ± 7.5 μmol/L compared to 8.5 ± 2.6 μmol/L in controls (p < 0.01) 2
- Prevalence: Up to 57% of hypothyroid patients have homocysteine levels exceeding the upper limit of normal sex-specific reference ranges 4
- TSH correlation: Multivariate analysis confirms TSH as the strongest independent predictor of elevated homocysteine, even after adjusting for age, folate, vitamin B12, and creatinine 2
Clinical Significance
The combination of hyperhomocysteinemia and the lipid abnormalities that occur in hypothyroidism creates a "dynamic atherogenic state" that may explain the accelerated atherosclerosis and increased cardiovascular risk observed in these patients 2, 4. Moderate hyperhomocysteinemia (fasting plasma total homocysteine 15-30 μmol/L) is explicitly recognized as being caused by hypothyroidism in clinical guidelines 1.
Treatment Implications
When hypothyroidism is identified as the cause of elevated homocysteine, thyroid hormone replacement should be the primary treatment 1. Studies demonstrate:
- Thyroid hormone replacement significantly decreases fasting homocysteine levels by approximately 44% (range -58% to -13%, p < 0.001) 4
- Homocysteine normalizes in 7 of 8 patients (87.5%) with elevated pretreatment values after achieving euthyroidism 4
- However, thyroid hormone alone may not completely normalize homocysteine levels in all patients 2
Important Caveats:
Hashimoto's thyroiditis adds complexity: Patients with autoimmune thyroiditis (Hashimoto's disease) have significantly higher homocysteine levels (median 19.7 μmol/L) compared to those with non-autoimmune hypothyroidism (16.2 μmol/L, p = 0.018), suggesting the immune-inflammatory component independently contributes to homocysteine elevation 5
Folate deficiency is common: Hypothyroid patients often have lower folate levels, which compounds the hyperhomocysteinemia 2. Consider checking folate and B12 levels, as supplementation may be needed in addition to thyroid hormone replacement.
Even subclinical changes matter: Recent evidence shows that even in euthyroid subjects, higher TSH levels within the normal range correlate with elevated homocysteine, and positive thyroid peroxidase antibodies (TPOAb) independently increase homocysteine risk 6.
Practical Approach
When evaluating a patient with elevated homocysteine:
- Check thyroid function (TSH, free T4) as hypothyroidism is a recognized treatable cause of moderate hyperhomocysteinemia
- Initiate thyroid hormone replacement when hypothyroidism is confirmed
- Recheck homocysteine 3-9 months after achieving euthyroidism to assess response 4
- Consider folate/B12 supplementation if homocysteine remains elevated despite euthyroidism, particularly given the lower folate levels often seen in hypothyroid patients 2
The guideline consensus is clear: when moderate hyperhomocysteinemia is present and hypothyroidism is identified, the best treatment is reversal of the underlying cause through thyroid hormone replacement 1.